Pharmaceutical and medicine manufacturing R&D intensity
Ratio of research and development expenditures to net sales for pharmaceutical and medicine manufacturing companies.
Unit Percent Industry Pharmaceuticals
The chart
Over time
United States over time. Forecasts are dashed with hollow markers; the underlying values are one click away under the chart.
Pharmaceutical and medicine manufacturing R&D intensity
United States, 2022 to 2023
Every record
All records
2 records · 1 region · 2022–2023
Primary documents
Sources
2 documents. Each links to the publisher's own copy.
| Document | Publisher | Published | Data points |
|---|---|---|---|
| Business R&D Performance in the United States Increases to $722 Billion in 2023 | NCSES | — | 1 |
| Discovery: R&D Activity and Research Publications | NCSES | — | 1 |
Cite & reuse
Cite this page
Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. To cite one figure, open its record: each carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.
StatOrigin. (2026). Pharmaceutical and medicine manufacturing R&D intensity. Retrieved from https://statorigin.org/indicators/pharmaceutical-and-medicine-manufacturing-r-d-intensity